Get all your news in one place.
100's of premium titles.
One app.
Start reading
Bangkok Post
Bangkok Post
World

SHOCKING: Sinopharm testing omicron vaccine - You Need To See This

(Reuters File Photo)

BEIJING: The Chinese drugmaker Sinopharm says a subsidiary has received approval for clinical trials of a new vaccine specifically to target the Omicron coronavirus variant.

Two vaccine candidates developed by units of China National Biotec Group (CNBG) have been approved for clinical trials as boosters in Hong Kong, the Sinopharm subsidiary said on Saturday.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.